2403683-24-7
2403683-24-7
Chemical Structure
Galegenimab
Synonym(s): FHTR 2163; RG 6147; RO 7171009
- CAS No.: 2403683-24-7
- Formula:N/A
- Molecular Weight:(47.71 kDa)
IUPAC Name: tert-butyl (2S,3S)-2-amino-3-methylpent-4-enoate
SMILES: [Galegenimab]
Biological Activity: Galegenimab (FHTR 2163) is a humanized monoclonal antibody Fab fragment targeting the HtrA1 trimer. Galegenimab is used in research on age-related macular degeneration (AMD)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Galegenimab | 99.91% | Galegenimab (FHTR 2163) is a humanized monoclonal antibody Fab fragment targeting the HtrA1 trimer. Galegenimab is used in research on age-related macular degeneration (AMD). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Jonathan B Lin, et al. Neuroprotection for Age-Related Macular Degeneration. Ophthalmol Sci. 2022 Jul 5;2(4):100192. [Content Brief]
- [2]. Eichenbaum DA, et al. Phase 2 Study of the Anti-High Temperature Requirement A1 (HtrA1) Fab Galegenimab (FHTR2163) in Geographic Atrophy Secondary to Age-Related Macular Degeneration. Am J Ophthalmol. 2025 Jul;275:14-26. [Content Brief]
